14-MYEL-09-CC (CC-4047-MM-007) Phase 3 comparing PVd vs Vd in R/R Myeloma

Grants and Contracts Details

StatusFinished
Effective start/end date6/1/158/31/15

Funding

  • Celgene: $8,600.00